Inference
$11.8M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Inference is currently valued at N/A as of October 14, 2025. The company has raised a total of $16.6M in funding.
Investment Perspective
Inference's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Inference Worth in 2025?
As of 2025, Inference is valued at N/A, based on the company's Seed Round funding round in October 14, 2025. This valuation positions Inference as one of the leading private companies in the sector.
Inference Valuation History
Inference's funding history demonstrates steady growth and investor confidence.
How Inference Valuation is Determined
Private company valuations like Inference's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Inference Valuation FAQs
Is Inference profitable?
Inference has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Inference's valuation compare to competitors?
Inference is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Inference IPO?
Inference has not announced plans for an initial public offering. Until an IPO, investors can access Inference shares through secondary market platforms.